0002008372-25-000002.txt : 20250604 0002008372-25-000002.hdr.sgml : 20250604 20250604162043 ACCESSION NUMBER: 0002008372-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250604 DATE AS OF CHANGE: 20250604 EFFECTIVENESS DATE: 20250604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rapalogix Health, Inc. CENTRAL INDEX KEY: 0002008372 ORGANIZATION NAME: EIN: 933155788 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-502595 FILM NUMBER: 251023373 BUSINESS ADDRESS: STREET 1: 228 PARK AVE S, SUITE 66643 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (650)856-3700 MAIL ADDRESS: STREET 1: 228 PARK AVE S, SUITE 66643 CITY: NEW YORK STATE: NY ZIP: 10003 D/A 1 primary_doc.xml X0708 D/A LIVE 0002008372 Rapalogix Health, Inc. 228 PARK AVE S. SUITE 66643 NEW YORK NY NEW YORK 10003 (650) 856-3700 DELAWARE None None Corporation true 2023 Rahul Mehta 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Executive Officer James Peyer 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Director Juliette Han 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Executive Officer Director Joan Mannick 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Director Brent Saunders 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Executive Officer Director Doris Day 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Director David Nicholson 228 Park Ave S. Suite 66643 New York NY NEW YORK 10003 Director Biotechnology Decline to Disclose 06b true 0002008372-24-000001 2023-12-22 true true false 0 13500000 9079616 4420384 Sale of shares of Series Seed Preferred Stock. false 24 0 0 0 false Rapalogix Health, Inc. /s/ Rahul Mehta Rahul Mehta Chief Executive Officer 2025-06-04